Atrial Fibrillation vs Atrial Flutter: How to Tell Them Apart

Atrial fibrillation and atrial flutter are both supraventricular tachyarrhythmias that produce palpitations, thromboembolic risk, and often a rapid ventricular rate. The core axis that separates them is atrial organization: fibrillation is chaotic atrial activity with no organized contraction, while flutter is an organized macro-reentrant circuit. This distinction is written all over the ECG.

How to tell them apart

FeatureAtrial fibrillationAtrial flutter
Underlying mechanismChaotic atrial electrical activity with no organized atrial contractionOrganized macro-reentrant circuit in the right atrium, typically around the tricuspid annulus (a reentry arrhythmia)
Atrial waveform on ECGNo P waves—replaced by fibrillatory waves creating an irregular baseline"Sawtooth" flutter waves, best seen in leads II, III, and aVF
Atrial rateDisorganized; no discrete atrial rate is measurableTypically 250–350 bpm
Ventricular rhythm (RR intervals)Irregularly irregular RR intervalsOften regular, because AV conduction is fixed (commonly 2:1 block)
Typical ventricular rateVariable, often 110–180 bpm if untreatedCommonly ~150 bpm with 2:1 AV block
Atrial contractionLost—leads to loss of atrial kick and reduced cardiac outputAtrial activation is organized within the reentrant circuit
Definitive ablation targetPulmonary vein isolation, increasingly used as first-line in appropriate patientsCavotricuspid isthmus ablation, which is very effective for typical flutter

The reasoning

Anchor on two ECG features: the atrial waveform and the regularity of the RR intervals. Absent P waves with an irregular fibrillatory baseline and irregularly irregular RR intervals define atrial fibrillation. Discrete sawtooth waves in II, III, and aVF with a typically regular ventricular response define atrial flutter. A regular narrow-complex tachycardia at about 150 bpm is classic for flutter with 2:1 block—look carefully for flutter waves buried in the QRS-T complexes. Both share management principles, so once identified, the same triad of rate control, rhythm control, and anticoagulation applies, with flutter being especially amenable to cavotricuspid isthmus ablation.

Key tests

  • 12-lead ECG: atrial fibrillation shows irregularly irregular RR intervals with fibrillatory waves and no P waves; atrial flutter shows regular sawtooth flutter waves, often with a regular ventricular response.
  • Inspection of the inferior leads (II, III, aVF): reveals the classic sawtooth flutter waves in atrial flutter, versus a chaotic fibrillatory baseline in atrial fibrillation.
  • Ventricular rate/conduction assessment: a ventricular rate near 150 bpm should raise suspicion for flutter with 2:1 conduction, prompting a search for hidden flutter waves.

What they share

  • Both are supraventricular arrhythmias managed with the same core strategies: rate control, rhythm control, and anticoagulation
  • Both produce a narrow QRS unless there is a bundle branch block or pre-excitation
  • Both carry thromboembolic (stroke) risk and require attention to anticoagulation
  • Both can present with palpitations and a rapid ventricular response
  • Rhythm control with electrical or pharmacologic cardioversion applies to both

Pitfalls

  • Atrial flutter with variable AV block can produce an irregular ventricular response, mimicking atrial fibrillation—inspect for organized sawtooth waves before concluding it is AF.
  • Do not treat flutter as benign: like AF, it carries thromboembolic risk and requires anticoagulation consideration.
  • In pre-excited AF (WPW), AV nodal blocking agents—adenosine, beta-blockers, calcium channel blockers, and digoxin—are contraindicated because they can accelerate conduction over the accessory pathway and precipitate ventricular fibrillation.
  • In valvular AF from moderate-to-severe mitral stenosis (or a mechanical valve), warfarin is required and CHA2DS2-VASc does not apply—anticoagulate regardless of score.

Practice this the way the exam tests it — on branching cases where your decisions shape the patient.